knowledge -WSS

knowledge

author：knowledge 2025-09-28 23:31:32 - browse：24

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： What Henrietta Lacks's story taught me about my role as a doctor

knowledge

WSS

Dark money group runs ads on China biotech bill

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Childbirth

Lab trade group sues FDA to halt regulation of lab

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Startling documents reveal new facets of Sacklers' opioid empire

Wikipedia

knowledge

Wikipedia

How to save PrEP access — and even expand it

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Activists slam private health insurers over coverage restrictions

Transgender women dream of pregnancy via uterus transplants

Alkermes shareholders re

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

BioMarin wins approval for gene therapy to treat hemophilia A

PrEP can help anyone prevent HIV. Why do so few people take it?

Continuity nursing helped my family in our darkest PICU moments

Severe heat forecast: Where scorching temperatures will persist over the next week

leisure time

The response to Covid

How to protect coverage of PrEP

Where does female orgasm come from? Scientists think they know

Statins reduce cardiovascular risk in people living with HIV

Childbirth

Where does female orgasm come from? Scientists think they know

focus

Wikipedia

knowledge

focus